Related Experiment Videos
Surgical prophylaxis in practice
1Department of Infectious Diseases, San Bortolo Hospital, Vicenza, Italy. fdl.vi@gpnet.it
Abstract:
The use of antibacterial prophylaxis of postoperative infections is firmly established within clean-contaminated procedures. For clean procedures, prophylaxis has traditionally been reserved for operations involving foreign-body implantation. However, evidence that postoperative infections from non-prosthetic clean procedures are highly under-reported suggests that prophylaxis is also advisable, at least for some non-prosthetic procedures, such as breast surgery and herniorrhaphy. Although cefazolin is recommended by current guidelines, cefuroxime and cefamandole have a broader antimicrobial spectrum and should be preferred in clean prosthetic surgery prophylaxis. In this type of surgery glycopeptides are not recommended for routine use but may have a role for major prosthetic implantation in units with a high incidence of methicillin-resistant staphylococci. In the case of clean-contaminated procedures, cefazolin is recommended for routine use, although colorectal procedures require an agent with improved anti-anaerobic activity. In addition, experience has shown that obstetric/gynaecological, gastroduodenal and biliary tract surgery and appendectomy all require broad-spectrum antibacterial prophylaxis. Suitable agents include cefoxitin, cefotetan, ureidopenicillins and beta-lactam/beta-lactamase inhibitor combinations. The traditional surgical classification scheme needs to be replaced with a classification that additionally accounts for patient-specific risk factors. The limitations of the current scheme may partly explain why current guidelines are so seldom followed in clinical practice.
Insights
Antibacterial prophylaxis is crucial for preventing postoperative infections, especially in clean procedures like breast surgery. Guidelines should be updated to include patient risk factors for better adherence.
Area of Science:
- Infectious Diseases
- Surgical Oncology
- Pharmacology
Background:
- Antibacterial prophylaxis is standard for clean-contaminated procedures.
- Prophylaxis in clean procedures traditionally focused on foreign-body implantation.
- Under-reporting of infections in non-prosthetic clean procedures suggests broader prophylaxis is needed.
Purpose of the Study:
- To review current guidelines for antibacterial prophylaxis in surgery.
- To evaluate the efficacy of different antibiotic agents for various surgical procedures.
- To propose improvements to surgical classification for better prophylaxis strategies.
Main Methods:
- Literature review of existing guidelines and evidence.
- Analysis of antibiotic spectrum and suitability for different surgical types.
- Evaluation of current surgical classification limitations.
Main Results:
- Cefazolin is recommended for clean-contaminated procedures, but broader spectrum agents (cefuroxime, cefamandole) are preferred for prosthetic surgery.
- Glycopeptides are reserved for high-risk MRSA cases.
- Specific procedures like colorectal, obstetric/gynecological, and gastrointestinal surgeries require broad-spectrum prophylaxis.
- Current guidelines are not always followed due to limitations in surgical classification.
Conclusions:
- Antibacterial prophylaxis should be considered for non-prosthetic clean procedures like breast surgery and herniorrhaphy.
- Antibiotic choice should be tailored to procedure type and potential pathogens, including anaerobic and MRSA coverage where necessary.
- A revised surgical classification incorporating patient risk factors is needed to improve guideline adherence and optimize prophylaxis strategies.